Sign In
Cook Children's
Patient Portal

Cook Children's Infectious Diseases

Doctor with young boy
alert icon

Appointment and visitation policy:

Time sensitive, emergent and urgent cases will still take place. Parents and guardians will be contacted if their child’s appointment/procedure needs to be rescheduled.

A maximum of one primary caregiver will be allowed per patient, per visit inside Cook Children’s pediatric specialties. Please designate the primary caregiver who will go into the room with your child upon arrival.

  • NO WALK INS. Please call for an appointment and we will help you.


Parents and families, as we continue to follow the recommendations from the CDC, if you have an appointment at our Dodson clinic, our urgent care centers, or any of our other clinics or primary care offices, please bring and wear your own cloth face covering from home. Learn how to make your own cloth face covering or mask here. Thank you for helping us keep everyone safe.

Cook Children’s is dedicated to your child's well-being:

To ease any concerns you might have, we're taking great precautions to create the safest environment possible for patients, families and staff. Read about the safeguards Cook Children’s has in place.

Cook Children's Infectious Diseases team offers care for children and teens with diseases caused by bacteria, parasites, fungi or viruses.

Promising drug, Miltefosine

New hope in fight against deadly brain-eating amoeba
On June 17, 2016, Cook Children's became the first hospital in Texas to carry Miltefosine, a drug that has shown success in treating Primary Amoebic Meningoencephalitis (PAM), the brain infection caused by the water-born amoeba, known as Naegleria fowleri. Until recently, Miltefosine was only available through the Centers for Disease Control and Prevention (CDC) and had to be shipped to hospitals on a patient-by-patient basis. Having Miltefosine on hand at Cook Children's means patients will not have to wait for a shipment to arrive, increasing their odds of survival. It also means quicker access to the drug for hospitals across Texas and the region.